Defining stroke risks in sickle cell anemia

Nature Genetics

Volumn 37, Issue 4, 2005, Pages 340-341

  Meschia, James F ^a   Pankratz, V Shane ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN BETA CHAIN;

AGE DISTRIBUTION; ANALYTIC METHOD; BAYES THEOREM; BLOOD FLOW VELOCITY; CEREBROVASCULAR DISEASE; DOPPLER ECHOGRAPHY; GENETIC ANALYSIS; HUMAN; MISSENSE MUTATION; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING; SHORT SURVEY; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; VALIDATION PROCESS;

ANEMIA, SICKLE CELL; CEREBROVASCULAR ACCIDENT; FETAL HEMOGLOBIN; GENETIC PREDISPOSITION TO DISEASE; HEMOGLOBIN, SICKLE; HUMANS; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 16844386404     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0405-340     Document Type: Short Survey

References (15)

1. Ohene-Frempong, K. et al. Blood 91, 288-294 (1998).
2. Driscoll, M.C. et al. Blood 101, 2401-2404 (2003).
3. Kwiatkowski, J.L. et al. Br. J. Haematol. 121, 932-937 (2003).
4. Hoppe, C. et al. Blood 103, 2391-2396 (2004).
5. Adams, G.T. et al. BMC Med. Genet. 4, 6 (2003).
6. Sebastiani, P. et al. Nat. Genet. 37, 435-440 (2005).
7. Adams, R. et al. N. Engl. J. Med. 326, 605-610 (1992).
8. Adams, R.J. et al. Ann. Neurol. 42, 699-704 (1997).
9. Adams, R.J. et al. N. Engl. J. Med. 339, 5-11 (1998).
10. Fullerton, H.J. et al. Blood 104, 336-339 (2004).
11. Adams, R.J. et al. Blood 103, 3689-3694 (2004).
12. Kral, M.C. et al. Pediatrics 112, 324-331 (2003).
13. Dhandapani, K.M. & Brann, D.W. Cell Biochem. Biophys. 39, 13-22 (2003).
14. Croizat, H. & Nagel, R.L. Am. J. Hematol. 60, 105-115 (1999).
15. Hoh, J. & Ott, J. Nat. Rev. Genet. 4, 701-709 (2003).